This segment encompasses the core business of Henan Lingrui Pharmaceutical, focusing on the research, development, production, and distribution of a diverse portfolio of pharmaceutical products. R&D activities include the formulation and testing of various dosage forms, such as plasters, tablets, capsules, and granules. The company utilizes advanced manufacturing technologies to ensure product quality and efficacy. Therapeutic areas covered include general health and wellness, with a focus on traditional Chinese medicine and essential medications. The patient impact is significant, as the company provides access to affordable and effective medicines for various health conditions. Market positioning is strong within China, with a competitive advantage in its established distribution network and product portfolio. Future opportunities include expanding the product pipeline and exploring international markets. Regulatory and clinical aspects are crucial, with adherence to GMP standards and rigorous clinical trials to ensure safety and efficacy. Partnerships with distributors and healthcare providers are essential for market access and patient reach.

This segment includes healthcare-related activities and other business operations. It encompasses the company's strategic partnerships and collaborations, such as the agreement with Jiuzhoutong Medical Group. The segment also includes the company's investment in research and development, focusing on innovation and excellence in the pharmaceutical sector. The company is committed to promoting health and enhancing the quality of life through innovative and high-quality pharmaceutical products. This segment also includes the company's efforts to expand its product pipeline through diversified means. The company's market positioning is strong within China, with a competitive advantage in its established distribution network and product portfolio. Future opportunities include expanding the product pipeline and exploring international markets. Regulatory and clinical aspects are crucial, with adherence to GMP standards and rigorous clinical trials to ensure safety and efficacy. Partnerships with distributors and healthcare providers are essential for market access and patient reach.